SOC Telemed Warrants
TLMDW
TLMDW was delisted on the 5th of April, 2022.
9 hedge funds and large institutions have $2.38M invested in SOC Telemed Warrants in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.
25% less funds holding
Funds holding: 12 → 9 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
96% less capital inflows, than outflows
Capital inflows: $429K | Capital outflows: $9.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ionic Capital Management
New York
|
+$279K |
| 2 |
Walleye Capital
New York
|
+$150K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
-$9.44M |
| 2 |
AQR Arbitrage
Greenwich,
Connecticut
|
-$319K |
| 3 |
BlueCrest Capital Management
St Helier,
Jersey
|
-$173K |
| 4 |
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
-$5K |
TLMDW Hedge Fund Activity: Q2 2021 in Review
9 of the 5,771 institutional investors tracked by Wall St. Rank reported a position in SOC Telemed Warrants (TLMDW) for Q2 2021, worth a combined $2.38M — down 80% from $11.8M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TLMDW and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Ionic Capital Management, adding an estimated $279K. The largest seller was BAMCO Inc, exiting entirely with an estimated $9.44M sold.
- 9 institutional investors held SOC Telemed Warrants (TLMDW) as of Q2 2021, down from 12 in Q1 2021.
- Funds reported $2.38M of SOC Telemed Warrants stock for Q2 2021, down 80% quarter-over-quarter.
- 1 fund opened new SOC Telemed Warrants positions in Q2 2021 and 4 closed out, a net change of -3 holders.
- The largest SOC Telemed Warrants buyer in Q2 2021 was Ionic Capital Management, an estimated $279K added.
- The largest SOC Telemed Warrants seller in Q2 2021 was BAMCO Inc, an estimated $9.44M sold.
Based on aggregated 13F filings for Q2 2021.